Literature DB >> 15034049

Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2.

Stéphanie Zundel1, Sandor Cseh, Monique Lacroix, Mads R Dahl, Misao Matsushita, Jean-Pierre Andrieu, Wilhelm J Schwaeble, Jens C Jensenius, Teizo Fujita, Gérard J Arlaud, Nicole M Thielens.   

Abstract

Mannan-binding lectin (MBL)-associated serine proteases (MASP-1, -2, and -3) are homologous modular proteases that each associate with MBL and L- and H-ficolins, which are oligomeric serum lectins involved in innate immunity. To investigate its physicochemical, interaction, and enzymatic properties, human MASP-3 was expressed in insect cells. Ultracentrifugation analysis indicated that rMASP-3 sedimented as a homodimer (s(20,w) = 6.2 +/- 0.1 S) in the presence of Ca(2+), and as a monomer (s(20,w) = 4.6 +/- 0.1 S) in EDTA. As shown by surface plasmon resonance spectroscopy, it associated with both MBL (K(D) = 2.6 nM) and L-ficolin (K(D) = 7.2 nM). The protease was produced in a single-chain, proenzyme form, but underwent slow activation upon prolonged storage at 4 degrees C, resulting from cleavage at the Arg(430)-Ile(431) activation site. Activation was prevented in the presence of protease inhibitors iodoacetamide and 1,10-phenanthroline but was not abolished upon substitution of Ala for the active site Ser(645) of MASP-3, indicating extrinsic proteolysis. In contrast, the corresponding mutations Ser(627)-->Ala in MASP-1 and Ser(618)-->Ala in MASP-2 stabilized the latter in their proenzyme form. Likewise, the MASP-1 and MASP-2 mutants were each activated by their active counterparts, but MASP-3 S645A was not. Activated MASP-3 did not react with C1 inhibitor; had no activity on complement proteins C2, C4, and C3; and only cleaved the N-carboxybenzyloxyglycine-L-arginine thiobenzyl ester substrate to a significant extent. Based on these observations, it is postulated that MASP-3 activation and control involve mechanisms that are different from those of MASP-1 and -2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034049     DOI: 10.4049/jimmunol.172.7.4342

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Structural insights into the innate immune recognition specificities of L- and H-ficolins.

Authors:  Virginie Garlatti; Nicolas Belloy; Lydie Martin; Monique Lacroix; Misao Matsushita; Yuichi Endo; Teizo Fujita; Juan Carlos Fontecilla-Camps; Gérard J Arlaud; Nicole M Thielens; Christine Gaboriaud
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

Review 2.  Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.

Authors:  Rikke Sørensen; Steffen Thiel; Jens C Jensenius
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway.

Authors:  Márton Megyeri; Veronika Harmat; Balázs Major; Ádám Végh; Júlia Balczer; Dávid Héja; Katalin Szilágyi; Dániel Datz; Gábor Pál; Péter Závodszky; Péter Gál; József Dobó
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

4.  Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.

Authors:  Isabelle Bally; Véronique Rossi; Thomas Lunardi; Nicole M Thielens; Christine Gaboriaud; Gérard J Arlaud
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

5.  Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1).

Authors:  Mikkel-Ole Skjoedt; Pietro Roversi; Tina Hummelshøj; Yaseelan Palarasah; Anne Rosbjerg; Steven Johnson; Susan M Lea; Peter Garred
Journal:  J Biol Chem       Date:  2012-08-01       Impact factor: 5.157

6.  Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome.

Authors:  Caroline Rooryck; Anna Diaz-Font; Daniel P S Osborn; Elyes Chabchoub; Victor Hernandez-Hernandez; Hanan Shamseldin; Joanna Kenny; Aoife Waters; Dagan Jenkins; Ali Al Kaissi; Gabriela F Leal; Bruno Dallapiccola; Franco Carnevale; Maria Bitner-Glindzicz; Melissa Lees; Raoul Hennekam; Philip Stanier; Alan J Burns; Hilde Peeters; Fowzan S Alkuraya; Philip L Beales
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

7.  Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.

Authors:  Minoru Takahashi; Yumi Ishida; Daisuke Iwaki; Kazuko Kanno; Toshiyuki Suzuki; Yuichi Endo; Yoshimi Homma; Teizo Fujita
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

8.  Localization and characterization of the mannose-binding lectin (MBL)-associated-serine protease-2 binding site in rat ficolin-A: equivalent binding sites within the collagenous domains of MBLs and ficolins.

Authors:  Umakhanth Venkatraman Girija; Alister W Dodds; Silke Roscher; Kenneth B M Reid; Russell Wallis
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

9.  The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.

Authors:  Christine Gaboriaud; Rajesh Kumar Gupta; Lydie Martin; Monique Lacroix; Laurence Serre; Florence Teillet; Gérard J Arlaud; Véronique Rossi; Nicole M Thielens
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

Review 10.  Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway.

Authors:  Russell Wallis
Journal:  Immunobiology       Date:  2006-12-18       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.